Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC)
SkinJect, Inc.
SkinJect, Inc.
US Dermatology Partners, Phoenix
Regeneron Pharmaceuticals
University of Southern California
Memorial Sloan Kettering Cancer Center
Incyte Corporation
National Cancer Institute (NCI)
Senhwa Biosciences, Inc.
Case Comprehensive Cancer Center
TuHURA Biosciences, Inc.
Institute of Oncology Ljubljana
University of Kansas Medical Center
Genzada Pharmaceuticals USA, Inc.
Xencor, Inc.
University of Zurich
Novartis
Novartis
Novartis
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Case Comprehensive Cancer Center
University of Arizona
Genentech, Inc.
Yale University
Blaze Bioscience Australia Pty Ltd
Roswell Park Cancer Institute
Bristol-Myers Squibb
National Cancer Institute (NCI)
Millennium Pharmaceuticals, Inc.
National Institutes of Health Clinical Center (CC)
UCSF Benioff Children's Hospital Oakland
Case Comprehensive Cancer Center
Roswell Park Cancer Institute
Shahid Beheshti University of Medical Sciences
Shahid Beheshti University of Medical Sciences